Our data suggested TRIM66 was significantly overexpressed in osteosarcoma tissues compared with that in bone cysts (Figure 1A, P < 0.05), which was consistent with the analysis on data from GEO dataset (Access ID: GSE3628) (Figure 1B, P < 0.05). Here, TRIM66 is linked to bone disorder.